INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2018

Increasing long-chain omega-3 intake has little or no effect on mortality or cardiovascular events, while plant-based ALA may slightly reduce cardiovascular events.

This systematic review assessed 79 RCTs evaluating increased long-chain omega-3 (LCn3) or alpha-linolenic acid (ALA) for cardiovascular outcomes. High-quality evidence showed little or no effect of LCn3 on all-cause mortality (RR 0.98, 95% CI 0.90 to 1.03) or cardiovascular events (RR 0.99, 95% CI 0.94 to 1.04), though LCn3 reduced triglycerides by ~15% in a dose-dependent manner. Increasing ALA probably made little difference to all-cause mortality (RR 1.01, 95% CI 0.84 to 1.20), but low-quality evidence suggested it may slightly reduce cardiovascular events (RR 0.95, 95% CI 0.83 to 1.07) and arrhythmia (RR 0.79, 95% CI 0.57 to 1.10).

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
112,059 adults at varying cardiovascular risk across 79 RCTs lasting at least 12 months
What was measured
All-cause mortality, cardiovascular mortality, CVD events, CHD mortality, stroke, and arrhythmia

THE PAPER

Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, AlAbdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L. Cochrane Database Syst Rev, 2018.

PubMed 30521670 ↗DOI 10.1136/bmj.38755.366331.2f ↗

Heart & arteriesNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.